Skip to main content
. Author manuscript; available in PMC: 2017 Sep 25.
Published in final edited form as: Am J Gastroenterol. 2017 Jan 17;112(3):441–446. doi: 10.1038/ajg.2016.582

Table 1.

Univariable Statistics Comparing Background Characteristics for Oozing vs. All Other Major SRH Combined for Placebo Treated Patients (N = 388)

Characteristic Oozing (Ib)
(N=163)
Other classes (Ia+IIa+IIb)
(N=225)
P-value*
Age > 65 years 68 (41.7%) 110 (48.9%) 0.10
Male gender 112 (68.7%) 155 (68.9%) 0.97
Previous ulcer complications 27 (16.6%) 14 (6.2%) 0.001
Ulcer size > 2 cm 12 (7.4%) 28 (12.4%) 0.13
H. pylori negative 59 (36.2%) 78 (34.7%) 0.76
NSAID’s 63 (38.7%) 93 (41.3%) 0.60
Epinephrine injection only 70 (42.9%) 71 (31.6%) 0.022
Shock 5 (3.1%) 14 (6.2%) 0.23
*

By Fisher’s exact test with Bailey’s method.